Fundraising FoxMedicxi — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Altesa BioSciences is a clinical-stage pharmaceutical company developing vapendavir, an orally administered antiviral targeting rhinovirus infections in patients with chronic lung diseases such as COPD and asthma.
BiotechHealthtechCollege Park, US
John Clerici(Executive Officer)inAndrew Drechsler(Executive Officer)Brett Giroir(Executive Officer, Director)
BoardNicholas Williams(Director)Jon Edwards(Director)in
Board seatMoncef Slaoui· per SEC Form D
Co-investorsGRA VentureForbionPitangoSanofi Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.